NEW YORK (GenomeWeb) – Sigma-Aldrich today reported third quarter revenue growth of 2 percent year over year as it nears the completion of a deal to be acquired by Merck KGaA.

The St. Louis-based research tools and chemicals firm reported total revenues of $703 million for the three months ended Sept. 30, up from $690 million for the third quarter of 2014. On an organic basis, sales were up 9 percent year over year, the firm said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.